Table 3 Profile of patients at their first clinic visit during reporting period Q4 2018 – Q4 2019, São Paulo
Diagnosed | Treated | Controlled (at the last visit) | Among all patients with data | |||||
|---|---|---|---|---|---|---|---|---|
Total N = 1752 | % | Total N = 1461 | % | Total N = 456 | % | Treated Crude OR (95% CI) | BP controlled Crude OR (95% CI) | |
Age (years) | ||||||||
18–29 | 13 | 0·7 | 7 | 0·5 | 3 | 0·7 | REF | REF |
30–44 | 152 | 8·7 | 111 | 7·6 | 34 | 7·5 | 2·3 (0·6, 8·6) | 1·0, (0·2,5·7) |
45–59 | 488 | 27·9 | 423 | 29·0 | 138 | 30·3 | 5·5 (1·5, 20·0) ¥¥¥ | 1·3 (0·3, 7·5) |
60–69 | 552 | 31·5 | 461 | 31·6 | 135 | 29·6 | 4·3 (1·2, 15·4) ¥¥ | 1·1 (0·3, 6·2) |
70–79 | 417 | 23·8 | 350 | 24·0 | 112 | 24·6 | 4·5 (1·2, 16·0) ¥¥ | 1·2 (0·3, 7·0) |
≥ 80 | 130 | 7·4 | 109 | 7·5 | 34 | 7·5 | 4·4 (1·1, 17·0) ¥¥ | 1·2 (0·3, 7·1) |
Missing age information | 0 | 0·0 | 0 | 0·0 | 0 | 0·0 | NA | NA |
Sex | REF: MEN | REF: MEN | ||||||
Women | 1232 | 70·3 | 1045 | 71·5 | 316 | 69·3 | 1·3 (1·1, 1·8) ¥ | 0·9 (0·7, 1·2) |
Missing sex information | 44 | 2·6 | 32* | 2·2 | 10 | 2·2 | NA | NA |
BP Categories (mmHg) | ||||||||
< 120 and < 80 mmHg | 141 | 8·0 | 113 | 7·7 | 43 | 9·4 | REF | REF |
120–129 or 80–84 mmHg | 326 | 18·6 | 261 | 17·9 | 110 | 24·1 | 1·0 (0·6, 1·7) | 1·2 (0·7, 1·8) |
130–139 or 85–89 mmHg | 212 | 12·1 | 175 | 12·0 | 59 | 12·9 | 1·2 (0·7, 2·1) | 0·9 (0·5, 1·4) |
140–159 or 90–99 mmHg | 500 | 28·5 | 415 | 28·4 | 125 | 27·4 | 1·2 (0·7, 2·0) | 0·8 (0·5, 1·2) |
160–179 or 100–109 mmHg | 365 | 20·8 | 330 | 22·6 | 93 | 20·4 | 2·3 (1·3, 4·1) ¥¥ | 0·8 (0·5, 1·2) |
≥ 180 or ≥ 110 mmHg | 121 | 6·9 | 113 | 7·7 | 26 | 5·7 | 3·5 (1·5, 9·2) ¥¥ | 0·6 (0·3, 1·1) |
Missing BP information | 87 | 5·0 | 54*** | 3·7 | 0*** | 0·0 | NA | NA |
CV Riska | ||||||||
Low | 34 | 1·9 | 32 | 2·2 | 18 | 3·9 | REF | REF |
Moderate/Intermediate | 45 | 2·6 | 41 | 2·8 | 19 | 4·2 | 0·6 (0·1, 4·8) | 0·7 (0·2, 1·7) |
High | 149 | 8·5 | 130 | 8·9 | 47 | 10·3 | 0·4 (0·0, 1·9) | 0·4 (0·2, 0·9) ¥ |
Missing | 1524 | 87·0 | 1258* | 86·1 | 372*** | 81·6 | NA | NA |